Fundz

Juvenescence has raised $76M in the first tranche of its Series B-1 funding, led by M42, to advance its therapeutics and enhance its medicine pipeline.

PRIVATEMay 26, 2025

Amount Raised

$76 Million

Round Type

Series B

OtherBiotechnology

Investors

M42

Description

Juvenescence Limited, a Ramsey, UK-based clinical stage AI-enabled biotech company, raised $76M in the first-close of its Series B-1 funding. The round was led by cornerstone investor M42, with participation from existing investors. The company intends to use the funds to advance its portfolio of therapeutics into clinical development and enhance its core medicine pipeline. Juvenescence is focused on developing novel medicines to extend healthy lifespan.

Quick answer

Juvenescence raised $76 Million in a Series B round, dated May 26, 2025. Investors: M42.

How much did Juvenescence raise?
Juvenescence raised $76 Million in a Series B round on May 26, 2025.
Who invested in Juvenescence?
M42 is named as investors in this round.
What does Juvenescence do?
Juvenescence is a biotechnology company focused on developing therapies aimed at extending healthy lifespan.
Where is Juvenescence based and how big is it?
Fundz records about 31 employees.
Who are the decision-makers at Juvenescence?
Fundz holds 2 contacts at Juvenescence. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Juvenescence that raised within 45 days of this round, from Fundz verified event records.

  • The Blue Box Biomedical Solutions raised $3.5M (Funding Round) on July 10, 2025.
  • Varda Space Industries raised $187M (Series C) on July 10, 2025.
  • Solence raised $1.9M (Seed) on July 10, 2025.
  • Nuclidium raised $98M (Series B) on July 10, 2025.
  • Renasant Bio raised $55M (Seed) on July 10, 2025.
  • Piur Imaging raised $6.5M (Funding Round) on July 10, 2025.

Who to call at Juvenescence, and when

A new round usually means Juvenescence is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Juvenescence raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Juvenescence, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Juvenescence. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Juvenescence

About

Juvenescence is a biotechnology company focused on developing therapies aimed at extending healthy lifespan. The company utilizes AI and machine learning in its drug discovery process. It has partnerships with leading healthcare firms to accelerate its development portfolio. Juvenescence aims to target age-related diseases through innovative therapeutic solutions.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Juvenescence raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contacts47 people are listed at Juvenescence. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Juvenescence's next move

See what Strategic adds

Funding Insights

What this usually means
Timeline to next round
Series B companies typically work for 15-20 months before raising new capital
Growth expectations
Series B companies are expected to scale rapidly and expand market reach

Juvenescence raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.